Ocular Manifestations of Fanconi Anaemia
Published on: August 30, 2025
Ocular Manifestations in Fanconi Anemia featured image
Article author photo

Mercy Chepkemoi

Bachelor in Medicine and Bachelor in Surgery (MBChB), <a href="https://www.mu.ac.ke/" rel="nofollow">Moi University</a>

Article reviewer photo

Patience Mutandi

BSc. Medical Science (U. of Leeds), MBBS (CMU), MPH (U. of Chester)

Introduction

Fanconi Anaemia (FA) is a rare genetic disorder characterised by bone marrow failure, congenital abnormalities, and a predisposition to cancer. FA primarily affects the body's ability to produce blood cells and repair DNA damage. This condition is typically inherited in an autosomal recessive pattern, meaning that a person must inherit two copies of the faulty gene (one from each parent) to develop the disease.

While FA is most commonly associated with haematological issues (blood disorders), it can also have significant effects on various organs and systems within the body, including the eyes. Ocular (eye) manifestations in individuals with FA can range from mild to severe and can profoundly impact vision and quality of life. These eye-related symptoms are crucial for early diagnosis and comprehensive management of the condition.

By exploring the ocular manifestations of FA, we can better understand this complex disorder and improve the quality of care for those affected. 

Overview of ocular manifestations in Fanconi anaemia

Prevalence of ocular symptoms in FA patients

Fanconi Anaemia (FA) is a rare genetic disorder, but among those affected, ocular symptoms are quite common. These symptoms can vary widely in their severity and type, but it is estimated that between 40% and 60% of FA patients will have ocular manifestations. This high prevalence underscores the importance of regular eye examinations for individuals diagnosed with FA, as early detection and management of eye problems can greatly improve quality of life.1,2

General impact of FA on ocular health

The impact of FA on ocular health is multifaceted and can affect various parts of the eye. Structural abnormalities such as microphthalmia (abnormally small eyes), coloboma (a defect in the eye's structure), and anophthalmia (absence of one or both eyes) are some of the more severe manifestations. These conditions can be present at birth and may significantly impair vision.3

In addition to structural abnormalities, FA can cause refractive errors like myopia (nearsightedness), hyperopia (farsightedness), and astigmatism (distorted vision). These issues affect how light is focused on the retina, leading to blurred vision, which can often be corrected with glasses or contact lenses.4

Retinal and optic nerve abnormalities are also associated with FA. Retinal degeneration, where the retina gradually deteriorates, can lead to progressive vision loss. Optic atrophy, the wasting away of the optic nerve, impairs the transmission of visual information from the eye to the brain, further affecting vision.

Cataracts, which cause clouding of the eye's lens, are more common in FA patients and can develop at a younger age, often requiring surgical intervention.5

Moreover, strabismus (misalignment of the eyes) and amblyopia (lazy eye) are frequent issues that can affect vision development, especially in children. These conditions, if left untreated, can lead to permanent vision impairment. Therefore, addressing these ocular manifestations through a combination of medical and surgical treatments is crucial for maintaining optimal eye health in FA patients.

Specific ocular manifestations in Fanconi anaemia

Structural abnormalities

Microphthalmia

Microphthalmia is a condition where one or both eyes are abnormally small. People with FA may experience microphthalmia as a result of developmental tasks during pregnancy. This condition can significantly affect vision, often leading to severe visual impairment or blindness in the affected eye.6

Coloboma

Coloboma refers to a defect in the structure of the eye, which can involve the iris, retina, choroid, or optic disc. It appears as a keyhole-shaped defect and can impair vision depending on its size and location. In FA, coloboma is a common structural abnormality that may necessitate specialised care to manage its impact on vision.2

Anophthalmia

Anophthalmia is the complete absence of one or both eyes, which is a severe but rare manifestation of FA. This condition results in total blindness in the affected eye(s) and requires comprehensive support and adaptive strategies to help individuals manage daily activities.

Refractive errors

Myopia

Myopia, or nearsightedness, is a common refractive error where distant objects appear blurry while close objects are seen clearly. In FA, myopia can occur more frequently and may necessitate corrective lenses, such as glasses or contact lenses, to improve vision.4

Hyperopia

Hyperopia, or farsightedness, is another refractive error where close objects are blurry while distant objects can be seen more clearly. This condition is also prevalent among people with FA and can be corrected with appropriate lenses to enhance near vision.

Astigmatism

Astigmatism is a condition where the cornea or lens has an irregular shape, causing distorted or blurred vision at all distances. It is common and can usually be corrected with specially designed lenses to improve vision clarity.

Retinal and optic nerve abnormalities

Retinal degeneration

Retinal degeneration involves the gradual deterioration of the retina, the light-sensitive tissue at the back of the eye. In FA, this can lead to progressive vision loss and may require regular monitoring and supportive treatments to manage symptoms and slow progression.5

Optic atrophy

Optic atrophy is the wasting away or damage of the optic nerve, which carries visual information from the eye to the brain. This condition can lead to significant vision loss and is a serious concern in FA patients. Early detection and intervention are crucial to managing its impact on vision.

Cataracts

Types of cataracts in FA

Cataracts in FA patients often appear as cloudiness in the eye's lens, which can lead to blurry vision and glare. Different types of cataracts, such as nuclear, cortical and posterior subcapsular cataracts, may occur, affecting vision to varying degrees.

Prevalence and age of onset

Cataracts are more common in FA patients and tend to develop at a younger age. This early onset necessitates regular eye examinations and may require surgical intervention to remove the cloudy lens and restore clear vision.3

Strabismus and amblyopia

Types of strabismus observed

Strabismus, or misalignment of the eyes, can manifest as esotropia (inward turning of the eye) or exotropia (outward turning of the eye) in FA patients. This condition can affect depth perception and binocular vision, often requiring treatment to correct the alignment.

Impact on vision development

Amblyopia, also known as lazy eye, can occur when one eye is significantly weaker than the other, leading to poor vision development in the affected eye. This condition is common in FA patients with strabismus and requires early intervention, such as patching the stronger eye, to encourage proper vision development in the weaker eye.

Diagnostic techniques

Genetic testing

Genetic testing plays a crucial role in diagnosing FA and identifying the specific mutations responsible for the disorder. This involves analysing a blood sample to look for known genetic abnormalities associated with FA. Genetic testing is often recommended for individuals with a family history of FA or when FA is suspected based on clinical features.3

Ophthalmologic examinations

Visual acuity tests

Visual acuity tests measure a person's ability to see at various distances. These tests help determine the degree of vision impairment and are essential for assessing the impact of ocular manifestations.

Fundoscopy

Fundoscopy is an examination of the interior of the eye, including the retina, optic nerve, and blood vessels. During this test, an ophthalmologist uses an ophthalmoscope to examine these structures and identify any abnormalities, such as retinal degeneration or optic atrophy.

Imaging techniques

Optical coherence tomography (OCT)

OCT is a non-invasive imaging technique that provides detailed cross-sectional images of the retina. It helps in diagnosing and monitoring retinal abnormalities and assessing the thickness of retinal layers.

Magnetic resonance imaging (MRI)

MRI is used to obtain detailed images of the eye and surrounding tissues, particularly useful for evaluating structural abnormalities and assessing the optic nerve.

Management and treatment

Regular monitoring and early detection

Regular eye examinations are crucial for individuals with FA to detect and manage ocular manifestations early. Early detection allows for timely intervention, which can help prevent or mitigate severe vision impairment.7

Medical interventions

Surgical options (e.g., cataract surgery)

For conditions like cataracts, where the lens becomes cloudy and impairs vision, surgical intervention may be necessary. Cataract surgery involves removing the cloudy lens and replacing it with an artificial lens to restore clear vision. Surgery is considered when cataracts significantly affect daily activities and quality of life.

Non-Surgical Treatments (e.g., glasses, contact lenses)

Non-surgical treatments address refractive errors such as myopia, hyperopia and astigmatism. Glasses and contact lenses can correct these vision issues and improve visual acuity. 

Genetic counselling and support

Genetic counselling provides essential support for families affected by FA. It involves discussing the genetic aspects of the disorder, understanding the likelihood of passing it on to future generations and exploring available options for managing the condition. Genetic counsellors can also help families navigate the emotional and practical aspects of living with FA, including coordinating care and connecting with support resources.3

Summary

Ocular manifestations in Fanconi Anaemia (FA) can significantly impact vision and overall quality of life. FA is a genetic disorder that affects multiple body systems, including the eyes. Key ocular symptoms include structural abnormalities like microphthalmia (small eyes), coloboma (defect in the eye’s structure), and anophthalmia (absence of eyes). Refractive errors such as myopia (nearsightedness), hyperopia (farsightedness), and astigmatism (distorted vision) are also common. Patients with FA may experience retinal degeneration, which leads to progressive vision loss, and optic atrophy, where the optic nerve deteriorates, affecting visual signal transmission. Cataracts, which cause clouding of the lens, are prevalent and often require surgical intervention. Additionally, conditions like strabismus (misalignment of the eyes) and amblyopia (lazy eye) can affect vision development, particularly in children. Early diagnosis through genetic testing and ophthalmologic examinations is crucial. Management involves regular monitoring, corrective lenses, and, when necessary, surgical treatments such as cataract removal. Genetic counselling provides support and guidance for affected families. Addressing these ocular manifestations with a comprehensive approach can help improve visual outcomes and quality of life for individuals with FA.

References

  1. Mehta PA, Ebens C. Fanconi anemia. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Bean LJ, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993 [cited 2024 Aug 4]. Available from: http://www.ncbi.nlm.nih.gov/books/NBK1401/
  2. Törnquist AL, Martin L, Winiarski J, Fahnehjelm KT. Ocular manifestations and visual functions in patients with Fanconi anaemia. Acta Ophthalmologica [Internet]. 2014 Mar [cited 2024 Aug 4];92(2):171–8. Available from: https://onlinelibrary.wiley.com/doi/10.1111/aos.12132
  3. Bhandari J, Thada PK, Puckett Y. Fanconi Anemia. PubMed. Treasure Island (FL): StatPearls Publishing; https://www.ncbi.nlm.nih.gov/books/NBK559133/#article-17534.s8 
  4. Graf CM, Nichele S, Siviero RB, Loth G, Trennepohl JP, Zinher MT, et al. Ocular manifestations in patients with fanconi anemia: a single-center experience including 106 patients. The Journal of Pediatrics [Internet]. 2022 Mar 1 [cited 2024 Aug 4];242:228-234.e1. Available from: https://www.sciencedirect.com/science/article/pii/S0022347621010787
  5. Chai SM, Mathur R, Ong SG. Retinal vasculopathy in fanconi anemia. Ophthalmic Surg Lasers Imaging Retina [Internet]. 2009 Jan [cited 2024 Aug 4];40(5):498–500. Available from: https://journals.healio.com/doi/10.3928/15428877-20090901-11
  6. Oppezzo A, Bourseguin J, Renaud E, Pawlikowska P, Rosselli F. Microphthalmia transcription factor expression contributes to bone marrow failure in Fanconi anemia. J Clin Invest [Internet]. 2020 Mar 2 [cited 2024 Aug 4];130(3):1377–91. Available from: https://www.jci.org/articles/view/131540
  7. Solomon PJ, Margaret P, Rajendran R, Ramalingam R, Menezes GA, Shirley AS, et al. A case report and literature review of Fanconi Anemia (Fa) diagnosed by genetic testing. Ital J Pediatr [Internet]. 2015 May 8 [cited 2024 Aug 4];41(1):38. Available from: https://doi.org/10.1186/s13052-015-0142-6
Share

Mercy Chepkemoi

Bachelor in Medicine and Bachelor in Surgery (MBChB), Moi University

Mercy is a seasoned medical writer with a background in medicine. She is a global health enthusiast and has several years of experience in research, writing, and editing. In addition, she enjoys community health volunteer work.

arrow-right